Patents by Inventor Haohan Tan

Haohan Tan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SUBSTITUTED PYRROLO [2, 3-D] PYRIDAZIN-4-ONES AND PYRAZOLO [3, 4-D] PYRIDAZIN-4-ONES AS PROTEIN KINASE INHIBITORS
    Publication number: 20190161489
    Abstract: Provided are certain compounds or pharmaceutically acceptable salts thereof which can inhibit kinase activity of Bruton's tyrosine kinase (BTK) and may be useful for the treatment of diseases like cancer, immunological disease and inflammation.
    Type: Application
    Filed: June 20, 2017
    Publication date: May 30, 2019
    Applicants: Shanghai Fochon Pharmaceutical Co., Ltd., Fochon Pharmaceuticals, Ltd.
    Inventors: Xingdong ZHAO, Weipeng ZHANG, Zhifang CHEN, Ling CHEN, Xianlong WANG, Zhifu LI, Rui TAN, Lijun YANG, Haohan TAN, Bin LIU, Kai RAN, Zongyao ZOU, Min LIN, Jing SUN, Weibo WANG
  • CERTAIN PROTEIN KINASE INHIBITOR
    Publication number: 20180291027
    Abstract: Provided are certain CDK4/6 inhibitors, pharmaceutical compositions thereof, and methods of use therefor.
    Type: Application
    Filed: April 28, 2016
    Publication date: October 11, 2018
    Inventors: Xingdong ZHAO, Tongshuang LI, Haohan TAN, Zhifang CHEN, Ling CHEN, Qihong LIU, Yue RONG, Lijun YANG, Xianlong WANG, Rui TAN, Zuwen ZHOU, Bin LIU, Min LIN, Lihua JIANG, Yanxin LIU, Li LINGHU, Jing SUN, Weibo WANG
  • Certain protein kinase inhibitors
    Patent number: 10087195
    Abstract: Provided are compound of formula (I) as certain CDK4/6 inhibitors, pharmaceutical compositions thereof, and methods of use thereof.
    Type: Grant
    Filed: May 27, 2015
    Date of Patent: October 2, 2018
    Assignees: SHANGHAI FOCHON PHARMACEUTICAL CO., LTD., CHONGQING FOCHON PHARMACEUTICAL CO., LTD.
    Inventors: Weibo Wang, Xingdong Zhao, Tongshuang Li, Qiang Tian, Huajie Zhang, Haohan Tan, Xianlong Wang, Qihong Liu, Zhifu Li, Weipeng Zhang, Zhifang Chen, Lihua Jiang, Yanxin Liu, Li Linghu, Min Lin, Jing Sun
  • Certain protein kinase inhibitors
    Patent number: 10022374
    Abstract: Disclosed herein are protein kinase inhibitors, more particularly pyridazine derivatives and pharmaceutical compositions thereof, and method of use thereof.
    Type: Grant
    Filed: December 15, 2016
    Date of Patent: July 17, 2018
    Assignee: Shanghai Fochon Pharmaceutical Co., Ltd.
    Inventors: Weibo Wang, Xingdong Zhao, Quan Yuan, Hailong Shi, Qiang Tian, Qihong Liu, Zuwen Zhou, Xianlong Wang, Zhifang Chen, Ling Chen, Haohan Tan, Bo Fang, Lihua Jiang, Yanxin Liu, Jing Sun, Fanxin Zeng, Tongshuang Li
  • CERTAIN PROTEIN KINASE INHIBITORS
    Publication number: 20170267696
    Abstract: Provided are compound of formula (I) as certain CDK4/6 inhibitors, pharmaceutical compositions thereof, and methods of use thereof.
    Type: Application
    Filed: May 27, 2015
    Publication date: September 21, 2017
    Inventors: Weibo Wang, Xingdong Zhao, Tongshuang LI, Qiang TIAN, Huajie ZHANG, Haohan TAN, Xianlong WANG, Qihong LIU, Zhifu LI, Weipeng ZHANG, Zhifang CHEN, Lihua JIANG, Yanxin LIU, Li LINGHU, Min LIN, Jing SUN
  • CERTAIN PROTEIN KINASE INHIBITORS
    Publication number: 20170105994
    Abstract: Disclosed herein are protein kinase inhibitors, more particularly pyridazine derivatives and pharmaceutical compositions thereof, and method of use thereof.
    Type: Application
    Filed: December 15, 2016
    Publication date: April 20, 2017
    Inventors: Weibo Wang, Xingdong Zhao, Quan YUAN, Hailong SHI, Qiang Tian, Qihong LIU, Zuwen Zhou, Xianlong Wang, Zhifang CHEN, Ling Chen, Haohan TAN, Bo FANG, Lihua Jiang, Yanxin Liu, Jing Sun, Fanxin Zeng, Tongshuang Li
  • Certain protein kinase inhibitors
    Patent number: 9567342
    Abstract: Disclosed herein are protein kinase inhibitors, more particularly novel pyrimidine derivatives and pharmaceutical compositions thereof, and method of use thereof.
    Type: Grant
    Filed: October 29, 2015
    Date of Patent: February 14, 2017
    Assignees: SHANGHAI FOCHON PHARMACEUTICAL CO., LTD., SHANGHAI INSTITUTE OF MATERIA MEDICA CHINESE ACADEMY OF SCIENCES
    Inventors: Weibo Wang, Meiyu Geng, Jian Ding, Xingdong Zhao, Jing Ai, Qiang Tian, Xia Peng, Weipeng Zhang, Hongbin Liu, Haohan Tan, Ling Chen
  • Certain protein kinase inhibitors
    Patent number: 9556171
    Abstract: Disclosed herein are protein kinase inhibitors, more particularly pyridazine derivatives and pharmaceutical compositions thereof, and method of use thereof.
    Type: Grant
    Filed: April 18, 2014
    Date of Patent: January 31, 2017
    Assignee: Shanghai Fochon Pharmaceutical Co., Ltd.
    Inventors: Weibo Wang, Xingdong Zhao, Quan Yuan, Hailong Shi, Qiang Tian, Qihong Liu, Zuwen Zhou, Xianlong Wang, Zhifang Chen, Ling Chen, Haohan Tan, Bo Fang, Lihua Jiang, Yanxin Liu, Jing Sun, Fanxin Zeng, Tongshuang Li
  • CERTAIN PROTEIN KINASE INHIBITORS
    Publication number: 20160083376
    Abstract: Disclosed herein are protein kinase inhibitors, more particularly pyridazine derivatives and pharmaceutical compositions thereof, and method of use thereof.
    Type: Application
    Filed: April 18, 2014
    Publication date: March 24, 2016
    Inventors: Weibo WANG, Xingdong ZHAO, Quan YUAN, Hailong SHI, Qiang TIAN, Qihong LIU, Zuwen ZHOU, Xianlong WANG, Zhifang CHEN, Ling CHEN, Haohan TAN, Bo FANG, Lihua JIANG, Yanxin LIU, Jing SUN, Fanxin ZENG, Tongshuang LI
  • CERTAIN PROTEIN KINASE INHIBITORS
    Publication number: 20160046638
    Abstract: Disclosed herein are protein kinase inhibitors, more particularly novel pyrimidine derivatives and pharmaceutical compositions thereof, and method of use thereof.
    Type: Application
    Filed: October 29, 2015
    Publication date: February 18, 2016
    Inventors: Weibo WANG, Meiyu GENG, Jian DING, Xingdong ZHAO, Jing AI, Qiang TIAN, Xia PENG, Weipeng ZHANG, Hongbin LIU, Haohan TAN, Ling CHEN
  • Certain protein kinase inhibitors
    Patent number: 9206166
    Abstract: Disclosed herein are protein kinase inhibitors, more particularly novel pyrimidine derivatives and pharmaceutical compositions thereof, and method of use thereof.
    Type: Grant
    Filed: November 5, 2013
    Date of Patent: December 8, 2015
    Assignees: Shanghai Institute of Materia Medica Academy of Sciences, Shanghai Fochon Pharmaceutical Co., LTD
    Inventors: Weibo Wang, Meiyu Geng, Jian Ding, Xingdong Zhao, Jing Ai, Qiang Tian, Xia Peng, Weipeng Zhang, Hongbin Liu, Haohan Tan, Ling Chen
  • CERTAIN PROTEIN KINASE INHIBITORS
    Publication number: 20140128387
    Abstract: Disclosed herein are protein kinase inhibitors, more particularly novel pyrimidine derivatives and pharmaceutical compositions thereof, and method of use thereof.
    Type: Application
    Filed: November 5, 2013
    Publication date: May 8, 2014
    Applicants: SHANGHAI iNSTITUTE OF MATERIA MEDICA ACADEMY OF SCIENCES, SHANGHAI FOCHON PHARMACEUTICAL CO., LTD.
    Inventors: Weibo WANG, Meiyu Geng, Jian Ding, Xingdong Zhao, Jing Ai, Qiang Tian, Xia Peng, Weipeng Zhang, Hongbin Liu, Haohan Tan, Ling Chen